James D. Clark - 03 Aug 2023 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
SVP, Cont & Chief Acct Officer
Signature
/s/ James D. Clark
Issuer symbol
CVS
Transactions as of
03 Aug 2023
Net transactions value
-$1,930,004
Form type
4
Filing time
04 Aug 2023, 17:41:13 UTC
Previous filing
04 Apr 2023
Next filing
15 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Sale $196,792 -2,631 -8.6% $74.79 27,826 03 Aug 2023 Direct F1
transaction CVS Common Stock Sale $1,733,212 -23,128 -83% $74.94 4,698 03 Aug 2023 Direct F2
holding CVS Common Stock (Restricted) 8,882 03 Aug 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVS Stock Option 9,050 03 Aug 2023 Common Stock 9,050 $78.05 Direct F3
holding CVS Stock Option 7,513 03 Aug 2023 Common Stock 7,513 $62.21 Direct F4
holding CVS Stock Option 24,240 03 Aug 2023 Common Stock 24,240 $54.19 Direct F5
holding CVS Stock Option 17,157 03 Aug 2023 Common Stock 17,157 $58.34 Direct F6, F7
holding CVS Stock Option 12,094 03 Aug 2023 Common Stock 12,094 $74.30 Direct F8
holding CVS Stock Option 6,756 03 Aug 2023 Common Stock 6,756 $101.09 Direct F9
holding CVS Stock Option 9,649 03 Aug 2023 Common Stock 9,649 $74.31 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Weighted average sales price; shares sold at a range of 74.79 to 74.80 per share.
F2 Weighted average sales price; shares sold at a range of 74.90 to 75.02 per share.
F3 Options became exercisable in four equal annual installments beginning on 4/3/2018.
F4 Options became exercisable in four equal annual installments, commencing 4/1/2019.
F5 Options became exercisable in four equal annual installments, commencing 4/1/2020.
F6 The number of shares subject to the option were calculated using a 30-day average price.
F7 Options became exercisable in four equal annual installments, commencing 4/1/2021.
F8 Option became exercisable in four equal annual installments, commencing 4/1/2022.
F9 Option became exercisable in four equal installments, commencing 4/1/2023.
F10 Option becomes exercisable in four equal annual installments, commencing 4/1/2024.